When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Your Guide to the 6 Most Common Types of Depression ... - AOL

   www.aol.com/6-types-depression-medications...

   Medications for Depression: An Overview. Antidepressants are a class of medications used very commonly to treat depression. In fact, nearly 13 percent of people 12 and over in the U.S. used ...

3. Your Guide to Every Antidepressant: SSRIs, SNRIs, TCAs & More

   www.aol.com/guide-every-antidepressant-ssris...

   List of SSRIs. Currently, several different SSRI antidepressants are used to treat depression, anxiety disorders and other conditions. They include: Citalopram (Celexa) is an SSRI used to treat ...

4. List of antidepressants - Wikipedia

   en.wikipedia.org/wiki/List_of_antidepressants

   This is a complete list of clinically approved prescription antidepressants throughout the world, as well as clinically approved prescription drugs used to augment antidepressants or mood stabilizers, by pharmacological and/or structural classification.

5. Escitalopram (Lexapro): Everything You Need to Know Before ...

   www.aol.com/escitalopram-lexapro-everything-know...

   As an SSRI antidepressant, escitalopram is commonly prescribed to treat depression. The FDA also approves it for the treatment of generalized anxiety disorder (GAD).

6. Antidepressant - Wikipedia

   en.wikipedia.org/wiki/Antidepressant

   The APA recommends antidepressant medication as an initial treatment choice in people with mild, moderate, or severe major depression, and that should be given to all people with severe depression unless ECT is planned. [30] Reviews of antidepressants generally find that they benefit adults with depression.

7. Treatment-resistant depression - Wikipedia

   en.wikipedia.org/wiki/Treatment-resistant_depression

   Ketamine has been tested as a rapid-acting antidepressant [13] for treatment-resistant depression in bipolar disorder, and major depressive disorder. [14] Spravato, a nasal spray form of esketamine, was approved by the FDA in 2019 for use in treatment-resistant depression when combined with an oral antidepressant. [15] [16]